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ABC transporters form one of the largest and ancient of protein families. ABC transporters 3
couple hydrolysis of ATP to vectorial translocation of diverse substrates across cellular 4
membranes. Many human ABC transporters are medically important in causing, for example, 5
multidrug resistance to cytotoxic drugs. Seven complete prokaryotic structures and one 6
eukaryotic structure were solved for transporters from 2002 to the present, and a wealth of 7
research is being conducted on and around these structures in order to resolve the mechanistic 8
conundrum of how these transporters couple ATP hydrolysis in cytosolic domains to substrate 9
translocation through the transmembrane pore. Many questions remained unanswered about 10










































































The ABC of ABC transporters.3
ATP-Binding Cassette (ABC) transporters are found in all phyla and constitute one of the 4
largest protein superfamilies [1] and [2]. A recent analysis of the full genomes from 13 diverse 5
organisms from the kingdoms, archaea, eubacteria, and eukarya identified sequences within 6
genes encoding the nucleotide-binding domains of ABC transporters as amongst the most 7
conserved phylogenic DNA sequences [3]. ABC transporters couple hydrolysis of ATP to 8
vectorial translocation of substrates across cellular membranes, typically against a 9
concentration gradient. Through their transport function these integral membrane proteins are 10
involved in diverse cellular processes such as maintenance of osmotic homeostasis, nutrient 11
uptake, resistance to cytotoxic drugs and antibiotics, cell division, bacterial immunity, 12
pathogenesis and sporulation, cholesterol and lipid trafficking, cellular immune response, and 13
developmental stem cell biology [4] and [5]. Many of the human ABC transporters are 14
medically important, including ABCC7/CFTR that causes cystic fibrosis by any of dozens of 15
mutations in the gene. A subclass of ABC transporters are associated with multidrug resistance, 16
through the extrusion of cytotoxic agents used in chemotherapy against tumours. ABCB1/P-17
glycoptotein/MDR1, ABCC1/MRP1, and ABCG2/BCRP ABC transporters appear to account 18
for nearly all of the MDR tumour cells in both humans and rodents. All of the medically 19
important ABC transporters can be located at: http://www.genenames.org/genefamily/abc.html; 20
and http://www.nutrigene.4t.com/humanabc.htm.21
22
Look at how they are built: different peas in the same pod?23
The architecture of ABC transporters comprises a conserved core structure of two 24



































































nucleotide-binding domains (NBDs). The four domains may be comprised of one, two or four 1
polypeptide chains, encoded by the same or different genes, which assemble into monomers, 2
homo- or heterodimers, or tetramers. Prokaryotes harbour both importers for nutrient uptake 3
(including amino acids, sugars, metal ions) and exporters (drugs, toxins, polysaccharides, 4
lipids, proteins), and eukaryotes only exporters [6] and [7]. For example, the K12 serotype of E. 5
coli contains 65 experimentally verified and putative ABC transporters. Of the 65 ABC 6
transporters listed, 50 are ABC importers and the remaining 15 are exporters [8]. Bacterial 7
ABC importers also contain a periplasmic binding protein that captures substrate and delivers it 8
to the transporter. The TMDs, which contain cytosolic as well as membrane spanning regions, 9
form the transmembrane (TM) pore and contain the substrate binding sites, while the NBDs 10
bind and hydrolyse ATP. The cytosolic regions of the TMDs, known as the intracytoplasmic 11
loops (ICLs), form the physical interface between the TMDs and NBDs and are thought to 12
coordinate ATP binding and hydrolysis with substrate binding and translocation. Sequence 13
analysis indicates that the consensus configuration of the TMDs is of two sets of six 14
hydrophobic TM spans, though there are notable exceptions among importers, with some 15
transporters having ten or more while others have fewer than six. The TMDs are thus not well 16
conserved in length or sequence, probably reflecting their role in binding diverse substrates. In 17
a functional ABC transporter, two TMDs form a selectively permeable pore or conduit through 18
the membrane. At any point in time, the TMDs are “gated” so that they are closed to one side 19
of the membrane, preventing passive diffusion of substrates.20
21
Each NBD is roughly an L-shape with two lobes comprising three subdomains. The larger 22
Lobe I includes a RecA- and F1-ATPase-like ATP-binding core subdomain [9] (Figure 1, blue), 23
containing the Walker A (GXXGXGKS/T) and B (DE) motifs, where ‘’ is any aliphatic 24



































































ABC-ATPases and which appears to play a predominately structural role [11]. Lobe II, also 1
known as the -helical subdomain (Figure 1, red), is attached flexibly to Lobe I and contains 2
the remotely located LSGGQ signature sequence that is unique to ABC-ATPase and defines the 3
family. In all ABC proteins, two ATP-binding cassette NBDs associate as a head-to-tail dimer, 4
with two ATPs sandwiched between the A and B motifs of one monomer and the signature 5
sequence of the other monomer [12] and [13]. This conformation has been observed in the 6
crystal structures of isolated NBD dimers, [13], [14], [15], [16], [17] and [18], and in some of 7
the complete ABC structures (see below), and is consistent with biochemical and sequence data 8
[19], [20], [21], [22] and [23]. The LSGGQ makes several main-chain and side-chain 9
hydrogen-bonded contacts with the ATP, is directly involved in catalysis of the ATP hydrolysis 10
reaction [24]. It is thought to play a role similar to the arginine finger observed in other P-loop 11
ATPases that extends from one domain into the active site of opposite domain [24]. In addition 12
to the three major motifs, a number of additional motifs and residues are involved in the ATP 13
binding and hydrolysis processes (see Glossary ‘Road Map’). The import or export of substrate 14
across the TMDs is coupled to ATP hydrolysis in an allosteric manner, but the precise 15
mechanics of the process are still to be solved [25], [26] and [27].16
17
ABC transporter crystal structures: is seeing believing?18
The publication between 2001 and 2005 of three erroneous structures of the prokaryotic lipid A 19
exporter MsbA [28] and [29] has highlighted the importance of rigorous assessment of x-ray 20
crystallographic structures against data derived from all other sources [26], [30], and [31]. 21
Herein, we adopt a circumspect approach to the whole transporter structures in attempting to 22





































































To date, one eukaryotic and ten prokaryotic ABC transporters have been crystallised, 1
representing seven different types of transporter, of which four of the structures are orthologs 2
of others. The seven transporter types display three apparently structurally unrelated TM folds 3
(Figure 2). One group comprises the BtuCD vitamin B12 importer from Escherichia coli [32]4
and HI1470/71 metal-chelate importer from Haemophilus influenzae [33] that display two 5
densely packed block-like 10-helix bundles forming a narrow chamber within the membrane 6
(Figure 2a). The second group contains: ModBC molybdate/tungstate importer from 7
Archaeoglobus fulgidus [34], ModBC from Methanosarcina acetivorans [35], MetNI 8
methionine importer from E. coli [36], and the MBP-MalFGK2 maltose permease from E. coli9
[37] and [38]. This group deploys 5 to 8 curved TM helices that form a relatively wide ‘tepee-10
shaped’ pore (Figure 2b). The third group comprises the Sav1866 multidrug exporter from 11
Staphylococcus aureus [39], the MsbA lipid flippase exporter from E. coli [40], and the mouse 12
multidrug exporter Mdr1a [41], each displaying a 6 + 6 TM helix arrangement forming two 13
large wing-like arcs (Figure 2c). Sav1866 and MsbA are close homologues of, and are 14
functionally related to, the human P-glycoprotein multidrug transporter (ABCB1 or MDR1). 15
The one structural feature common to all seven transporter types is the presence of a short 16
helix, part of the ICL from each TMD, which contacts and interacts directly with the adjacent 17
NBD, binding in a groove formed between Lobes I and II of the NBD. This helix, known as a 18
“coupling helix”, is proposed to represent a part of the transmission interface whereby binding 19
and hydrolysis of ATP in the NBDs is coupled to conformational transitions in the TMDs that 20
effect solute translocation.21
22
Which transporter mechanism? Switches, tweezers, and clothes pegs.23
Despite the structurally unrelated nature of the TM folds, a unified model for ABC importers 24



































































ABC structures [42]. This model is based on the allosteric model for membrane pumps 1
proposed by Jardetsky [43]. To function as a pump, a membrane protein need only meet three 2
structural conditions: (1) It must contain a cavity in the interior large enough to admit the 3
solute; (2) It must be able to assume inward- and outward-facing configurations such that the 4
cavity is alternately open to one side of the membrane; and (3) It must contain a binding site for 5
the transported species within the cavity, the affinity of which is different in the two 6
configurations. In this model, pumps for different molecules need differ only in the specificity 7
of binding sites, and the same pump molecule could be adapted to translocate more than one 8
molecular species.9
10
The ABC alternating access [42] and [44] and switch [45] and [46] models predict that a 11
common mechanism of substrate translocation is utilised by both ABC importers and exporters 12
(Figure 3). Substrate enters the translocation pore through the TMDs, which are open to the 13
substrate delivery side and closed to the other side of the membrane, forming a partial conduit 14
across the membrane. Transport of substrate across the membrane involves structural 15
reshuffling of the TMDs, physically closing them to the substrate delivery side and opening 16
them on the opposite side of the membrane. Within the NBDs, ATP-driven closure of the NBD 17
dimer interface, in a tweezers like motion [17], causes a reduction in the distance between the 18
intracellular sides of the TMDs. This is mediated through the coupling helices (CH), those 19
regions of the TMD intracytoplasmic loops that interact directly with the NBD (see above). The 20
change in proximity of the CHs triggers a flipping of the TMDs from an inward-facing to 21
outward-facing conformation in a clothes peg-like motion. ABC importers may now accept 22
substrates from their cognate periplasmic binding proteins (BPs), whereas ABC exporters may 23
extrude drugs or other solutes to the extracellular side of the membrane. ATP hydrolysis drives 24





































































The Metal-chelate importers: subtle but complex.3
The ABC importer systems BtuCD and HI1470/71 mediate the uptake of metal-chelate species 4
and are comprised of homodimeric NBDs and TMDs. Three whole transporter structures have 5
been determined for these proteins; none of the structures contain substrate or nucleotide and 6
resolutions range from 3.2 Å (BtuCD) to 2.4 Å (HI1470/1). The three structures are similar, 7
with a Root Mean Square Deviation (RMSD) for structurally equivalent residues of 2.4 Å 8
between the BtuCD complex and HI1470/71 [33]. Each BtuC and HI1471 TMD subunit 9
comprises 10 TM helices intricately packed in a block-like structure.10
11
The E. coli BtuCD was crystallised both with and without the BP BtuF. A cavity between the 12
BtuC subunits was proposed to embody an outward-facing translocation pore. The cavity has a 13
maximum diameter of about 9 Å [33] and tapers toward the extracellular mouth, such that the 14
vitamin B12 substrate (diameter > 15 Å) would require further conformational changes in the 15
TMD vestibule or cavity to enter and traverse the pore. In the BtuCD-F structure (Figure 2a), 16
one BtuC subunit is in a different conformation compared to that observed in BtuCD, resulting 17
in an asymmetric TMD:TMD conformation with no TM cavity or “pore”. There are no 18
substantial structural changes of the BtuD NBD subunits in BtuCD-F when compared to 19
BtuCD, which remain in an open conformation. BtuF is bound at the extracellular face in an 20
open, ligand-releasing conformation. Both structures are proposed to represent intermediate 21
conformations in the translocation cycle [33].22
23
HI1470/1 was crystallised in the absence of its cognate BP. A TM cavity formed by the 24



































































conformation. The cavity has a maximum diameter of 11 Å [33]. Notably, both the HI1471 1
TMDs have a conformation similar to that observed in the BtuC subunit in the BtuCD-F 2
structure (above) that differs from that in the BtuCD structure. The main structural differences 3
between the two TMD conformations observed for this group were in the orientation of the 4
central pore-forming helices, particularly TM helix 5, which lines the substrate translocation 5
pore [33]. Thus, the transition from the inward to outward facing channel is due primarily to a 6
change in tilt of the pore-lining helix, TM helix 5 (Figure 4), while an asymmetric 7
conformation of the TMD subunits results in an occluded channel, two together of one 8
conformation results in an inward- or outward-facing channel.9
10
Since the nucleotide-free states of BtuCD and HI1470/1 were crystallised in putative outward-11
and inward-facing conformations respectively, no correspondence between nucleotide state and 12
transporter conformation was found [33]. The authors suggested that the substitution of the 13
native bilayer with detergent, and/or crystal lattice contacts might have shifted the equilibrium 14
between inward- and outward-facing conformations [33]. Nevertheless, the closer juxtaposition 15
of the NBDs in BtuCD relative to HI1470/1 is consistent with the idea that the outward-facing 16
conformation of the transporter corresponds to the closed, double ATP-bound state of the NBD 17
dimer (Figure 3).18
19
Taken together, these structures suggested a mechanism whereby a translational shift of the 20
NBDs along the NBD dimer interface is coupled to a twisting motion of the associated 21
membrane-spanning subunits to interconvert inward- and outward-facing conformations. Thus, 22
the NBDs move in a direction perpendicular to the tweezers-type motion observed between 23
different nucleotide states of MalK, the NBD of the maltose permease [33]. More recently, 24



































































on the crystal structures. This study supported a model in which the NBDs remain in contact; 1
ATP binding followed by formation of the NBD sandwich dimer drives opening of the TM 2
channel at the intracellular face [32]. This is opposite to the mechanism for the other groups 3
where NBD dimer formation opens the TMDs at the extracellular face and the NBDs undergo a 4
cycle of association and dissociation. In contrast to this, a recent functional characterisation of a 5
related bacterial heme ABC transporter found that ATP-hydrolysis triggered release of 6
substrate at the cytoplasmic face, consistent with the models for the other structural groups 7
[48]. These latest two studies are germane to the final section of this review on NBD models 8
for binding and hydrolysis of ATP.9
10
Maltose, methionine, and molybdenum transporters: symmetry and asymmetry.11
The crystallisation of the apo (nucleotide-free) A. fulgidus ModBC-A complex revealed another 12
unique structural architecture of the TMDs. ModBC was crystallised in complex with its BP, 13
but in contrast to the asymmetric occluded pore observed in BtuCD-F, the TMDs of ModB are 14
closed to the substrate-loaded BP and extracellular side, and open to the intracellular side. The 15
homodimeric TMDs come together to form a wide inward-facing tepee (Figure 2b), and are 16
structurally symmetric. An N-terminal TM helix from each TMD swaps over to pack against 17
the outside of the helical bundle formed by the opposite TMD, but the TMD-NBD domain 18
swapping motif found in ABC exporters (below) is absent. A subsequent structure of M. 19
acetivorans ModBC, crystallized without the ModA BP, revealed a similar inward-facing 20
architecture [35]. More recently, the high-affinity methionine importer, MetNI [36], sharing the 21
same architectural fold, was crystallised in an inward-facing, nucleotide-free conformation. 22





































































The crystal structure of the full maltose transporter complex, MalFGK2, reveals that the 1
heterodimeric TMDs contain six (MalG) and eight (MalF) helices, respectively, with each 2
having a structurally conserved core of six helices related by a pseudo-twofold symmetry. This 3
conserved core is similar to that observed for ModB and MetN, retaining the cross-over N-4
terminal helix observed in ModB. In contrast to the ModBC-A structure, however, the MalK 5
NBDs form a closed dimer with bound ATPs, and the TMDs are open to the extracellular side 6
and closed to the intracellular side of the membrane, forming a large solvent-filled cavity that 7
reaches halfway across the predicted membrane bilayer from the periplasmic surface. The 8
maltose BP is bound to the extracellular rim of the TMDs in an open conformation, sealing the 9
pore, and the maltose substrate is bound to MalF, making no direct contacts to residues of 10
MalG [37]. In the substrate-binding site, ten residues contact the bound maltose, conferring 11
specificity and stabilizing substrate binding. Six of these residues had been identified through 12
genetic studies to severely decrease or eliminate maltose transport [37]. Interestingly, it appears 13
that some bacterial importers lack substrate binding sites in the pore, with substrate specificity 14
governed by which binding protein attaches [8] and [49].15
16
The core structures of MalF, MalG, ModB and MetN are quite similar, with maximum RMSDs 17
for structurally conserved residues under 2 Å, less than the overall resolution of the complete 18
structures. These structures are generally regarded as establishing a conserved architecture for 19
this group, consistent with their close evolutionary relatedness [50]. A model for transport was 20
proposed in which, on ATP binding to the inward-facing conformation (Figure 2b), the tepee 21
shape will invert, alleviating a hydrophobic gate and prising open the lobes of the BP allowing 22
substrate to permeate into the pore. Comparison of the ModBC and MalFGK2 structures 23
suggests that the TMDs rotate in an essentially rigid body movement between the two 24



































































was strongly supported most recently with the publication of the inward-facing maltose 1
permease structure [38], with comparison of the two maltose permease conformations 2
indicating that alternating access involves rigid-body rotations of the TM subdomains coupled 3
to the closure and opening of the NBD interface. Thus, in stark contrast to the metal chelate 4
transporters, the mechanism for this architectural group does not appear to involve significant 5
intrasubunit conformational changes in the TMDs, nor structural asymmetry within the TMD 6
dimer. Furthermore, the NBDs are proposed to move in a direction perpendicular to that 7
postulated for the metal chelate transporters.8
9
Although the proposed mechanism for this group does not involve asymmetry between the 10
TMDs, questions of asymmetry nevertheless arise. For example, does ModB have a substrate 11
binding site, and if so, does the substrate also bind only to one TMD, as is the case for 12
MalFGK2? Given that the TMDs in the BP-less M. acetivorans ModBC structure are exactly 13
symmetrical [35], it would appear that unless asymmetry were introduced into the ModB 14
dimer, the asymmetric BP [51] could bind to it in one of two equivalent ways. If the outward-15
facing conformation was also symmetrical, this would also be true of substrate binding to the 16
TMDs. What role does asymmetry play, if any, in the mechanism of this architectural group? 17
For MalFGK2, binding of ATP to the NBDs triggers high-affinity binding of the BP to 18
extracellular regions of the TMDs [52]. The BP is required to close the NBD dimer interface 19
[53] and, presumably, ATP hydrolysis requires binding of substrate to the outward-facing 20
TMDs. For this architectural group, since the BP and the substrate must interact with the TMD 21
subunits in an asymmetric manner, how do both TMDs exchange equivalent signals to and 22
from their respective NBDs?23
24



































































The TMD structure of the three ABC exporters crystallised, Sav1866 [39], [54], the revised 1
MsbA [40], and Mdr1a [41], exhibits yet another unique ABC transporter architecture (Figure 2
2c,d). There are nine published structures for these ABC exporters with resolutions ranging 3
from 3.0 Å for the ADP bound form of Sav1866 to 5.5 Å for the nucleotide-free (apo) MsbA 4
structures, For the latter, C coordinates only are available. The nucleotide-bound 5
conformations of Sav1866 and MsbA are almost identical, with an RMSD of < 2.2 Å between 6
the C positions of the monomers [40]. The structure of each half-transporter comprises six 7
TM helices in the TMD, followed by a canonical ABC transporter NBD, covalently joined to 8
the intracellular extension of TM6. Of the six TM helices in each half-transporter, TMs 2-6 9
extend significantly beyond the predicted extent of the bilayer into the cytoplasm, having an 10
average length of almost 70 Å. The ICLs between TM helices 2 and 3 and between TM helices 11
4 and 5, (ICL1 and ICL2) each form a pair of antiparallel -helices, connected by an 8-12 12
amino acid -helical section, CH1 and CH2, respectively. These sections of the ICLs are the 13
most distal to the membrane and form the interface with the NBDs (Figure 2d).14
15
Perhaps the most striking and emblematic feature of the nucleotide-bound Sav1866 and MsbA 16
structures is that ICL2 from each TMD crosses over to contact exclusively the NBD from the 17
opposite monomer in the dimeric arrangement, while ICL1 predominately, although not 18
exclusively, contacts the NBD within its own protomer. Although the possibility of domain 19
swapping involving the ICLs had been essayed earlier on the basis of modelling [55], this result 20
was generally unexpected. Thus, ICL1 and the intracellular extension of TM6 from one 21
protomer combine with ICL2 from the opposite protomer to form a 5-helix globular domain 22
that is stabilised by internal hydrophobic packing and associated predominately with the NBD 23
covalently linked to the respective TM6. The domain swapping continues through the TM 24



































































majority of their inter-helical contacts with TM helices from the opposite protomer, resulting in 1
a lobular or winged appearance of the TMDs. In the nucleotide-bound state, the TMD wings 2
form a chamber, closed at the cytoplasmic side by the apposition of the two ICL domains and 3
splaying outward in a “V” shape to flank the wide extracellular opening of the chamber (Figure 4
2c). The gap between the two wings in the exporters runs approximately perpendicular with 5
respect to the NBDs to that observed for the TMDs in the structures of the importers (Figure 2). 6
Thus, the switching between inward and outward facing conformations in exporters would 7
involve completely different coupling of conformational changes in the TMDs to the putative 8
opening and closing of the NBD dimer.9
10
Although the Sav1866 and revised “closed” AMP-PNP-bound MsbA structures are generally 11
considered to fit well with other experimental data, some inconsistencies warrant mention.12
Dong et al. [56] investigated the structure of MsbA in liposomes trapped in four intermediate 13
states, including apo and AMP-PNP-bound. Notably, this study found that residues in the N-14
terminal half of TM helix 6, (residues 284-296), showed very low accessibility to the aqueous 15
medium in all phases of the transport cycle examined. These accessibility data are in excellent 16
agreement with cysteine mutagenesis studies of the equivalent region (residues 331-343) in 17
ABCB1 [57], which showed that, with the exception of residue 343, this region was 18
inaccessible to a hydrophilic reagent in all phases of the transport cycle. From the nucleotide-19
bound Sav1866 and MsbA structures, the N-terminal half of TM helix 6 is expected to form 20
part of the interior wall of the TMD chamber, with its N-terminus projecting beyond the bilayer 21
into the extracellular milieu and its C-terminal residues deeper within the TMD channel. Since 22
the outward-facing Sav1866 and MsbA are open to the cell exterior, the structures clearly 23
indicate that residues in the N-terminal half of TM6 would be accessible to the bulk solvent 24




































































Whilst cysteine cross-linking experiments using ABCB1 [58], CFTR [59], TAP [60], and 2
Yor1p [61] have provided convincing evidence that these transporters deploy a similar domain 3
swapping TMD:NBD interface to that observed in the Sav1866, results from other studies of 4
the ABCB1 TM regions do not fit quite as well. Homology models of ABCB1 based on the 5
Sav1866 structure [62] and [63] were used to assess cross-linking data for ABCB1 for residues 6
within the TM segments, indicating that while the majority of the data fit the models quite well, 7
a significant number of discrepancies remain. These may be resolved by structures of8
alternative conformations. Finally, recent low to medium resolution EM images of ABC 9
exporters have tended to support the nucleotide-bound Sav1866 and MsbA structures [64] and 10
[65]. Nevertheless, it is also true that EM studies of ABCB1 [66], [67], [68], [69] and [70], and 11
of the related exporters human MRP1 [67] and TAP1/2 [71], consistently show that, in the 12
nucleotide-free state, the TMDs are open to the extracellular face. This does not agree with the 13
exporter structures in that the nucleotide-bound and apo states cannot both be open at the 14
extracellular face (Figure 2c).15
16
Most recently, the whole transporter structure of mouse Mdr1a P-glycoprotein, which shares 17
87% sequence identity with human P-glycoprotein, was published [41]. In this nucleotide-free 18
structure, the NBDs are separated by ~30 Å and the inward-facing conformation of the TMs 19
results in a large internal cavity open to both the cytoplasm and the inner leaflet of the 20
membrane. Structures were obtained both with and without bound substrate, but substrate-21
binding did not alter the transporter conformation. The inward-facing structure does not allow 22
substrate access from the outer membrane leaflet nor the extracellular space but would freely 23
allow both lipids and substrates to enter the putative substrate binding chamber from the 24



































































hydrophobic vacuum cleaner, binding substrates directly from the inner leaflet of the 1
membrane [72].2
3
The Mdr1a structure shares the domain swapping and NBD:TMD interface observed in the 4
prokaryotic exporters. However, the inward-facing conformation of the TMDs is not achieved 5
by a rigid body motion as in the maltose permease and related importers, nor by the subtle 6
intrasubunit changes observed in the metal chelate importers. Rather, the transition between the 7
inward- to outward-facing conformation is achieved by radical rearrangement of the TM 8
helices with respect to that observed in nucleotide-bound Sav1866 and MsbA, in a manner 9
similar to that observed in the nucleotide-free MsbA structures [40], reminiscent of a child’s 10
origami fortune teller game. In the nucleotide-free Mdr1a conformation, the gap between the 11
pseudo-symmetrical TM wings runs transverse with respect to the NBDs to that observed in the 12
outward-facing nucleotide-bound conformations of Sav1866 and closed MsbA structures. It 13
was noted that further opening of the TM cavity and concomitant movement apart of the NBDs 14
may be required to allow some substrates access to the cavity. Notably however, the structure 15
does not appear to resolve many of the discrepancies with cysteine cross-linking data and the 16
correlation between the residues comprising the putative drug-binding sites and those identified 17
by extensive biochemical studies. Curiously, the apo and drug-bound structures do not differ in 18
conformation and the manner in which substrate binding promotes ATP binding [46] is not 19
apparent. However, at 3.8 Å, the crystal structure is of relatively low resolution and only 65% 20
of residues are located in favoured regions of the Ramachandran plot, suggesting further 21
refinement is needed. Finally, as observed above, the closed extracellular face does not appear 22
consistent with extensive EM data of nucleotide-free P-glycoprotein.23
24



































































Prior to the publication of full length structures of ABC transporters, in line with evolutionary 1
theory and as predicted in the Jardetsky model [43] (above), it was generally expected that they 2
would have evolved from a common progenitor, with a conserved overall structure and 3
mechanism adapted to different substrates. Thus, the different types of TM structures observed 4
in the crystallographic studies have led to the suggestion that the TMDs of ABC transporters 5
may have several unrelated ancestors [46]. However, sequence analysis has shown a good 6
correlation between the phylogenetic classification of NBDs, TMDs and BPs [73], [74] and 7
[75], which is not supportive of this idea [76].8
9
The evolutionary time required for the NBD to pair with a new domain and form an efficiently 10
functioning transporter for a particular substrate would be considerably greater than that 11
required to adapt an existing working design to a new substrate. Phylogenetic analysis of ABC 12
genes concluded that the uptake function was separated from the export function early before 13
the divergence between prokaryotes and eukaryotes and that this separation occurred once in 14
the history of ABC systems [75]. Since this division is at the root of the ABC transporter NBD 15
phylogenetic tree, pairing of the NBD to new domains would have occurred subsequent to this 16
event, indicating that grafting to new domains would have had to outstrip development of an 17
existing design. Nonetheless, since the phylogeny of ABC genes closely correlates with 18
substrate specificity, the structural data suggest that yet more unique ABC transporter TMD 19
folds may exist [44]. It will be intriguing to learn what evolutionary pressures stimulated the 20
development of new designs, particularly considering the very diverse range of substrates that 21
the exporter folds of P-glycoprotein and the MRPs are adapted to transport.22
23
To date, the only correlation suggested between a specific property of the substrate and the 24



































































sequence, and this seems reasonable since larger substrates would require a larger TM channel 1
[32]. However, in comparing for example the vitamin B12 and methionine importer TMDs, we 2
find that although BtuC (326 residues) is significantly larger than MetI (208 residues), BtuC 3
does not appear to devote the additional residues to expanding the channel relative to that 4
observed for MetI, but rather curiously folds into an intricately and densely packed 10-helix 5
bundle with a narrower channel formed at the TMD:TMD interface than that observed for 6
MetI. What attributes of the BtuC structure could conceivably make it peculiarly suited to the 7
vitamin B12 substrate? The answer to these questions may, however, be more complex than 8
simply the structure of the TMD. For example, the TMD and NBD components of the 9
prokaryotic arginine and histidine permeases are identical, consisting of a single copy of each 10
transcribed HisM and HisQ protein for the TMDs and two copies of the transcribed HisP as the 11
NBD. The functional difference between the two transporter systems arises from the presence 12
of an arginine-specific (ArgT) or histidine-specific (HisJ) BP, which delivers the import 13
substrate to the transporter complex. This “modular” expression reduces the necessity for entire 14
gene duplication and allows for greater genetic variation in bacterial ABC transporter genomes.15
16
Harnessing the engine: is one as good as two? 17
The homology of ABCs in all classes and their similarity in structure strongly suggest that 18
these components of ABC transporters all work in the same way [49]. The whole transporter 19
structures indicate that the contacts between the NBDs and the TMDs are significantly more 20
extensive in the nucleotide-bound exporters than in the importers, with no equivalent in the 21
importers to CH1 (Figure 5). In exporters, CH1 interacts directly with regions contacting the 22
nucleotide adenine ring, acting to sequester the nucleotide and the active site from the bulk 23
solvent in the ATP-bound state. Thus, calculation of the solvent accessible surface with the 24



































































importer structure, atoms of the pyrophosphate moiety, the conserved glutamine, and the 1
Walker B aspartate and glutamate, are all directly accessible to the bulk solvent, while in 2
Sav1866 and closed MsbA they are not.3
4
Is the lack of an equivalent to CH1 in importers at odds with notion that the NBDs all function 5
the same way? It is very likely that in occluding the nucleotide, CH1 in exporters would alter 6
the dielectric and environment of the highly conserved active site and act to detect the 7
nucleotide. Interestingly, it has been shown for both ABC importers and exporters that8
vanadate trapping, which mimics the pentacoordinate transition state of ATP hydrolysis, results 9
in an occluded state of the nucleotide in the active site [76] and [78]. Since this occlusion does 10
not occur in the isolated NBDs, it must require the participation of the TMDs. In the exporters, 11
CH1 occludes the nucleotide and sits along side CH2 (Figure 5), which binds in the groove 12
between Lobes I and II, as does the single CH in the importers. Thus, the single CH in 13
importers cannot occlude the nucleotide as does CH1 in exporters. How is the nucleotide 14
occluded in vanadate-trapped importers?15
16
The nucleotide-binding domains: an open and shut case?17
The most subscribed model for the functioning of the NBDs was based originally on the 18
evidence of crystal structures, which show that in the ATP-bound state, the NBDs form a 19
closed dimer with two ATP molecules bound at the dimer interface, while nucleotide-free 20
structures consistently show the NBDs physically separated. Thus, in this model (Figure 6a), 21
variously known as the ‘processive clamp’ [13] and [22], ‘tweezers-like’ [17], or ‘switch’ 22
model [45] and [46], each spatially separated NBD of a dimer pair binds a molecule of ATP, 23
followed by the formation of a closed NBD dimer and sequential hydrolysis of the two ATPs. 24



































































of ADP and renewed ATP binding. Pi release may occur prior to NBD separation. The alternate 1
opening and closing of the NBD dimer is proposed to couple directly to the change in the 2
inward-outward orientation of the TMDs that enable substrate translocation (see above). It is 3
notable that the majority of support for the existence of the symmetrical sandwich dimer comes 4
from structural and biochemical studies in which NBD catalysis of ATP hydrolysis was 5
abrogated, either through mutation of catalytic residues, the use of non-hydrolysable ATP 6
analogues or absence of the catalytic divalent metal [79].7
8
The nucleotide-free states of full transporters or dimeric NBDs (e.g. MalK) exhibit significant 9
differences, suggesting that no strict geometric constraints exist in this state [34]. Indeed, in 10
some structures (MetNI, MalK dimer, MsbA open), the LSGGQ and the opposite Walker A are 11
more than 20 Å apart, across what would be a solvent filled gap in vivo, and thus the NBDs are 12
not in direct contact. Although it is proposed that ATP binding and the subsequent tight closure 13
of the NBD dimer, provides the free energy for the “power stroke” of the transport complex 14
[13], [14], [17], [22], [46], [80] and [81], it is difficult to envisage how ATP binding could 15
achieve this. The distances between the NBD monomers and their variable geometries in the 16
apo state, together with the fact that MgADP- and MgATP2- differ by only one charge unit, 17
makes it appear unlikely that electrostatic forces could bring the monomers together at all, far 18
less in a sufficiently timely and accurate manner as to be a crucial step of a conserved protein 19
mechanism. Indeed, what could be the relevance of the apo state observed in the crystal 20
structures given that the physiological ATP concentration is 10 times greater than the Km of 21
ATP binding to the NBD [37]? In regard to these ideas, it is interesting to note that the earlier 22
version of the switch model [46] was modified recently [82] to state that the close proximity of 23
the NBDs in intact ABC transporters suggests that the structural differences between the open 24




































































Prior to the first crystal structures revealing the double ATP-bound NBD sandwich dimer, it 2
was regarded generally as a central tenet that the ABC transporter NBDs hydrolysed ATP 3
alternately and that the active sites were closely coupled throughout the catalytic cycle, 4
consistent with an asymmetric mechanism with respect to the NBD monomers, the so-called 5
“alternating sites” model (Figure 6b) [76]. This notion, however, although founded on classic 6
biochemical studies, has been, in the main, eschewed in the wake of the crystal structures; and 7
asymmetry and tight coupling between the active sites play only a peripheral and ill-defined 8
role in currently popular mechanistic schemes. The source of the incompatibility is in large part 9
because the structures indicate unambiguously that the NBDs must move apart in a 10
symmetrical rigid body fashion to enable the opening of the pseudo-symmetrical TMDs to the 11
cytoplasm. In this mechanism, there appears no need for the NBDs to hydrolyse ATP 12
alternately and although attempts have been made to incorporate these ideas [83] into the so 13
called “switch model”, the purpose of alternating ATP hydrolysis in this context remains 14
obscure.15
16
Notwithstanding the popular view, a structural model for the NBD function consistent with the 17
earlier alternating sites scheme (Figure 6b) [76] was proposed. In this “constant contact” model 18
(Figure 6c), the active sites hydrolyze ATP and open alternately, with the two NBDs remaining 19
in contact in the opposite, unopened composite site [26] and [84]. This model was articulated20
further in recent MD simulation studies of the MJ0796 NBD dimer in different nucleotide-21
bound states [85] and [86]. These studies revealed how in the ATP/ADP bound NBD dimer, the 22
ADP-bound site can open sufficiently for nucleotide release without the need for the NBD 23




































































Enzymological data from functional whole transporters support an asymmetric model for NBD 1
dimer function. EPR analysis of homomeric MsbA consistently showed the existence of 2
asymmetric environments for all spin label pairs placed in the Walker A and LSGGQ motifs, 3
and within the Q-, H- and D-loops (see Glossary) [79], [87] and [88]. Cysteine cross-linking 4
experiments using ABCB1 revealed that the trapping of ATP, or transition state analogue at 5
one active site, resulted in reduced contact between Lobe I of NBD1 and the ICLs [58],6
consistent with opening of one active site while the other is closed. In addition, in vanadate-7
trapped ABCB1, the nucleotide-bound active site is occluded while the other is empty and 8
accessible to the bulk solvent [89]. Other data support the notion that the NBDs do not 9
dissociate. Experiments with the functional maltose importer showed that the helical 10
subdomains do not move apart substantially during the catalytic cycle [90]. Finally, 11
accessibility data from functional MsbA suggested that the LSGGQ region has low solvent 12
accessibility throughout the ATP hydrolysis cycle [88] contradicting its solvent accessible 13
placement as observed in nucleotide-free whole transporter structures.14
15
16
Concluding remarks: quo vadis?17
Although significant breakthroughs in structural studies of ABC transporters have continued 18
apace since early this decade, it is probably fair to say that our clarity regarding their molecular 19
mechanisms has not increased in direct proportion. This is due in part to the difficulty in 20
obtaining structures of the same transporter in different stages of the transport cycle. Whilst a 21
unified model for transport in importers and exporters was proposed to project the Jardetsky 22
concept [43] onto ABC transporters [44], it was suggested recently that the metal chelate group 23



































































differs from that earlier inferred from the BtuCD, BtuCDF and HI1470/71 structures (see 1
above) and the mechanism for this architecture awaits further elaboration.2
3
The situation appears far clearer cut with respect to the maltose permease group, with structures 4
of the inward- [38] and outward-facing [49] maltose permease structures illustrating both states 5
of the two-phase model very well. Nevertheless, much is still required to understand how these 6
transporters work. In particular, whilst it is clear that signals between the NBDs and 7
extracellular regions must occur, how these are propagated and coordinated do not appear to be 8
revealed by the structures, nor addressed in current models. For exporters, significant questions 9
regarding their mechanism remain. Even the now well-regarded Sav1866 structure is 10
constrained conformationally by the intertwined TMD ‘wings’ and domain-swapped NBD 11
ICLs, prompting the authors to suggest that the two subunits are unlikely to move 12
independently and their maximum separation during the transport cycle is therefore limited 13
[39]. This inference disagrees with the conformations observed in the nucleotide-free MsbA 14
and Mdr1a structures, in which the NBDs are more than 30 Å apart. In addition, although the 15
location of the substrate-binding sites appears to be revealed in the Mdr1a structures, the 16
structural basis of substrate-stimulated ATP hydrolysis remain unknown, despite the existence 17
of nine structures and a wealth of data for ABC transporters.18
19
Perhaps the central conundrum that emerges from consideration of the coupling of the NBDs to 20
the TMDs is that the notion of a single substrate-binding site, formed by a pair of symmetrical 21
TMDs and alternating between inward- and outward-facing conformations, is difficult to 22
reconcile convincingly with an alternating asymmetric functioning in the NBDs. This is 23
because it would require one hydrolysis event to alter the conformation of the substrate-binding 24



































































which at least for homodimeric transporters, seems unlikely if not impossible. The NBD switch 1
model is the logical consequence of the single-substrate binding site idea, but even it cannot 2
escape from notions of asymmetry because the NBD dimer has two equal substrate-binding 3
sites that cannot behave in a symmetrical manner at all times. Notably, prior to the whole 4
structures, a “two-cylinder engine” model for asymmetric functioning of the TMDs was 5
proposed for P-glycoprotein based wholly on biochemical data [91].6
7
It is clear that many significant questions remain with respect to the structure and mechanism 8
of ABC transporters and it would appear that answers must await more structures of 9
transporters from each group in different stages of the transport cycle. We hope that the 10
questions asked and observations made in this review will help to stimulate thought and 11
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Figure 1. The ABC Nucleotide Binding Domain.5
Three-dimensional structure of an ABC transporter NBD dimer. Ribbon diagram of the 6
MJ0796 ABC ATPase dimer (1L2T.pdb). One monomer is coloured with the ATP-binding core 7
subdomain (blue) and the antiparallel β subdomain (green), together comprising Lobe I. The α-8
helical subdomain or Lobe II is coloured red. ATP is shown in ball and stick form with carbon 9
yellow, nitrogen blue, oxygen red and phosphorous tan. The opposite monomer and ATP are 10




Figure 2. Crystal structures of the full transporters resolved to date.15
These fall into three general architectural types. The TMDs (blue and purple) of the binding-16
protein dependent ABC importers have two general conformation types: (a) that of the densely-17
packed 10 TM helix HI1470/1 (2NQ2.pdb), with only subtle tilt changes in the central pore-18
lining helices (red) throughout the transport cycle; or (b) the inverted tepee conformation of the 19
M. acetivorans ModBC (with BP docked) (2ONK.pdb), in which the TMDs undergo large 20
scale structural rearrangements induced by NBD (orange and gold) dimerisation and separation 21
during the transport cycle. The two ABC exporters crystallised, Sav1866 [39] and Mdr1a [41] 22
depict TMD helical domain swapping and the same NBD:TMD interface, but differ in the 23
conformation of the TMDs, with the nucleotide-free Mdr1a deploying an ‘inverted tepee’ 24



































































TMDs, which form divergent open wings in the nucleotide-bound state. (d) Front view of 1
Sav1866 depicting the two coupling helices (short, almost horizontal purple and blue cylinders 2
just above the NBDs).3
4
5
Figure 3. Simple two-state scheme for ABC importers.6
In the absence of substrate, the transporter is in a conformation in which the NBD dimer 7
interface is open and the translocation pathway is exposed only to the cytoplasm (left panel). 8
Interaction of substrate-bound BP with the closed extracellular side of the TMDs in the 9
presence of ATP, triggers a global conformational change in which the NBDs close to promote 10
ATP hydrolysis, substrate-bound BP becomes tightly bound to the TMDs, and both BP and 11
TMDs open at the periplasmic surface of the membrane to facilitate the transfer of substrate 12
from the BP to a binding site in the membrane (centre panel). Following ATP hydrolysis, 13
which destabilizes the NBD dimer, the transporter returns to the inward facing state and the 14
substrate completes its translocation across the membrane (right panel).15
16
17
Figure 4. The densely packed TMDs of BtuCD and HI1470/71.18
These ABC transporters show relatively subtle conformational changes between the nucleotide-19
free and nucleotide-bound states, with the major structural rearrangements occurring as a 20
pivoting motion in TM5 and its short extramembrane extension, TM5a (coloured red in TMD1 21
and blue in TMD2). (a) In the apo conformation of BtuCD (1L79.pdb), the outwards facing 22
conformation is characterised by a narrowing of the distance between the two TM5s, closing 23
the TMD to the intracellular side. (b) The crystal structure of BtuCD in complex with its 24



































































nucleotide bound conformation of HI1470/1 (2NQ2.pdb) shows the two TM5s spayed apart 1
towards the cytosolic side of the membrane, with the helices parallel and the cavity slightly 2
open to the cytoplasm.3
4
5
Figure 5. The Transmission Interface.6
Interaction of the coupling helices (CH) of the TMD intracytoplasmic loops with the NBD. 7
Ribbon diagram of the Sav1866 NBD (2ONJ.pdb) with Lobe I yellow, Lobe II green and the 8
Q-loop purple. Key structural elements discussed in the text are labelled. The ATP analogue 9
AMP-PNP is shown in ball and stick form with carbon grey, nitrogen blue, oxygen red and 10
phosphorous tan. The Sav1866 CHs are shown in C trace with CH1 blue and CH2 red. The 11
NBDs from six whole ABC importer structures were superimposed on the Sav1866 NBD using 12
the “best fit with structural alignment” option in SwissPDBviewer [92]. The CHs of the 13
importers are shown in C trace with BtuCD (1L7V.pdb) grey, BtuCD-F (2QI9.pdb) orange, 14




Figure 6. Scheme for the catalytic cycle of the NBD dimer.19
The three current models for ATP binding and hydrolysis. NBDs are depicted as blue and 20
orange semi-circular blocks, with the dimer closed, fully open, or partly opened, as rendered in 21
each model. TMDs are not shown.22
23
(a) Switch model [45] and [46]. Step I: in the resting state the nucleotide-free NBDs are in an 24



































































two ATPs drives the formation of the closed NBD dimer. In some transporters ATP binding to 1
the two sites is proposed to be a stochastic process while in others one site has higher affinity 2
for nucleotide. Step III: the two ATP molecules are hydrolysed sequentially with the hydrolysis 3
products remaining bound to the protein. Step IV: sequential release of Pi and then ADP 4
restores the transporter to its basal configuration [46].5
6
(b) Alternating sites model [76]. The catalytic pathway is shown in a number of intermediate 7
states I-VI. Initial loose binding of ATP at both sites triggers formation of the closed NBD 8
dimer (States I => II => III). The occluded ATP conformation occurs at state III, with only one 9
ATP bound tightly and committed to hydrolysis. This ATP (bold type in State III) enters the 10
transition state and forms Pi and ADP (III => IV). Pi and ADP are released as the dimer opens 11
(V, VI), and binding of new ATP would occur. Thus, in contrast to the switch model (Figure 12
6a), hydrolysis of one ATP is sufficient to drive the NBD dimer to the fully open state, product 13
release and rebinding of a new ATP molecule. The transporter is proposed to retain a 14
“memory” of which site last hydrolysed ATP such that ATP is subsequently hydrolysed in the 15
opposite site resulting in alternating ATP hydrolysis [76] and [81]. 16
17
(c) Constant-contact model [84], [85] and [86]. For each possible state of the NBD active site 18
there are two distinct substates, either occluded (closed) or open (allowing nucleotide 19
exchange), or in the case of the empty site, high or low affinity for nucleotide. Each active site 20
cycles in the sequence: ATP-open, ATP-occluded, ADP(+Pi)-occluded, ADP-open, empty-low 21
affinity, empty-high affinity. The two active sites function 180 degrees out of phase with 22
respect to this cycle and ATP hydrolysis alternates between the opposite sites. The NBDs 23
remain in contact throughout the catalytic cycle, with opening and closing of the active sites 24



































































I: the ATP-bound active site is closed and with opposite site empty. ATP hydrolysis occurs. 1
Step II: with hydrolysis products still bound in the occluded active site, the empty site switches 2
to high affinity, enabling ATP binding. Step III: ATP binding to the empty site and Pi release 3
from the occluded post-hydrolysis site promotes opening of the ADP-bound site and closing of 4
the ATP-bound site. Step IV: ADP release from the open site enables ATP hydrolysis in the 5
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